Biomarkers of antiangiogenic therapy.
10.3881/j.issn.1000-503X.2010.04.001
- Author:
Chun-mei BAI
- Publication Type:Editorial
- MeSH:
Angiogenesis Inhibitors;
therapeutic use;
Antineoplastic Agents;
therapeutic use;
Biomarkers;
Humans;
Neoplasms;
drug therapy
- From:
Acta Academiae Medicinae Sinicae
2010;32(4):361-365
- CountryChina
- Language:Chinese
-
Abstract:
Antiangiogenic therapy has entered clinical practice and shown good clinical benefits. However, no validated biomarker has been confirmed to be useful for screening patients who will respond to antiangiogenic therapy. Many systemic, circulating, tissue and imaging biomarkers are emerging and need to be prospectively validated.
